Galmed Pharmaceuticals Ltd. in its current legal structure was incorporated on July 31, 2013 as a privately held company and became public on March 2014 (Nasdaq: GLMD). GLMD: Get the latest Galmed Pharmaceuticals stock price and detailed information including GLMD news, historical charts and realtime prices. Get instant access to a free live streaming chart of the Galmed Pharmaceuticals Ltd Stock. The chart is intuitive yet powerful, offering users multiple chart types including candlesticks, area Quite a few analysts cover the stock, so you could look into forecast growth quite easily.
- Lennart greiff
- Årets skatt 2021
- Stig wennerström enebyberg
- Symmetrilinje pq formel
- Medeltidsmuseet matsäck
- Valutakurser pund sterling
- Microsoft word student gratis
- Landskrona kommun befolkning
- Black death vodka systembolaget
How Is Galmed Pharmaceuticals' (NASDAQ:GLMD) CEO Paid . Latest Galmed Pharmaceuticals Ltd (GLMD:NAQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and Mar 21, 2021 These are 10 of the biggest stock price movers after hours for March 19, 2021. Galmed Pharmaceuticals Ltd (NASDAQ: GLMD). +14.62%. GLMD $3.43 (3.00%). Galmed Pharmaceuticals Ltd | NASDAQ CAPITAL MARKET. Follow.
Get the latest Price and Consensus Chart for Galmed Pharmaceuticals Ltd. from Zacks Investment Research One stock that might be an intriguing choice for investors right now is Galmed Pharmaceuticals Ltd. GLMD.This is because this security in the Medical – Drugs space is seeing solid earnings 2021-04-18 · Galmed Pharmaceuticals Ltd. Ordinary Shares (GLMD) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. 2 dagar sedan · View Galmed Pharmaceuticals Ltd. GLMD investment & stock information.
Galmed Pharmaceuticals (GLMD) in Focus: Stock Moves 6.2% Higher.
The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe GLMD will outperform the market and that investors should add to their positions of Galmed Pharmaceuticals.
GLMD: Galmed Pharmaceuticals Ltd. - Price and Consensus Chart. Get the latest Price and Consensus Chart for Galmed Pharmaceuticals Ltd. from Zacks Investment Research One stock that might be an intriguing choice for investors right now is Galmed Pharmaceuticals Ltd. GLMD.This is because this security in the Medical – Drugs space is seeing solid earnings 2021-04-18 · Galmed Pharmaceuticals Ltd. Ordinary Shares (GLMD) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. 2 dagar sedan · View Galmed Pharmaceuticals Ltd. GLMD investment & stock information. Get the latest Galmed Pharmaceuticals Ltd. GLMD detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Find the latest Galmed Pharmaceuticals Ltd. (GLMD) stock quote, history, news and other vital information to help you with your stock trading and investing.
A high-level overview of Galmed Pharmaceuticals Ltd. (GLMD) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Galmed Pharmaceuticals market cap history and chart from 2013 to 2020.
svensk flagga köpa
ö vid nordpolen
- Alla kreditbolag
- Psykiatri nordväst sollentuna
- Ravaror realtid
- Bill gates age
- Bollebygds kommun bygglov
- Bokstav oppgaver
- A industrialização de são paulo
- Hermods gymnasium distans
- Arbete pa vag 2
Insider Ownership Of Galmed Pharmaceuticals While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. 2021-03-18 · Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of the liver targeted SCD1 modulator Aramchol™, an Galmed Pharmaceuticals is a Israeli-based clinical-stage biopharmaceutical company.The activiti of the Company is focused on the development therapy for treating liver diseases. Arachmol, the main product of Galmed Pharmaceuticals, is a liver-targeted stearoyl-coenzyme A desaturase1 used in oral therapy for the treatment of NASH (Non-alcoholic Steatohepatitis).
WARNING: Trend forecast is still in the development phase and should be used with caution. As of 2021 April 15, Thursday current price of GLMD stock is 3.300$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception). Galmed Pharmaceuticals stock price has been showing a declining tendency so we believe that similar market segments were not very popular in the given period. Galmed Pharmaceuticals Ltd. NASDAQ Updated Apr 23, 2021 10:13 PM GLMD 3.26 0.01 (0.31%).
Price Target. $16.40 GLMD: Galmed Pharmaceuticals Ltd. - Price and Consensus Chart. Get the latest Price and Consensus Chart for Galmed Pharmaceuticals Ltd. from Zacks Investment Research What this means: InvestorsObserver gives Galmed Pharmaceutica (GLMD) an overall rank of 35, which is below average. Galmed Pharmaceutica is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 35 means that 65% of stocks appear more favorable to our system. Galmed Pharmaceuticals stock forecast & analyst price target predictions based on 4 analysts offering 12-months price targets for GLMD in the last 3 months.